Zimmer Biomet Holdings (ZBH) Cash from Financing Activities (2009 - 2026)

Zimmer Biomet Holdings' Cash from Financing Activities history runs 18 years deep, the most recent figure standing at -$369.2 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 164.16% year-over-year to -$369.2 million; the TTM figure through Mar 2026 stood at -$618.6 million (down 538.72% YoY), while the FY2025 annual figure was $326.0 million, up 167.29% from the prior year.
• Cash from Financing Activities was -$369.2 million for Q1 2026 at Zimmer Biomet Holdings, up from -$897.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $575.4 million in Q1 2025 to a low of -$897.0 million in Q4 2025.
• Historically, Cash from Financing Activities has averaged -$121.6 million across 5 years, with a median of -$146.0 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Cash from Financing Activities sank 415.9% in 2022, then soared 1248.5% in 2025.
• A 5-year view of Cash from Financing Activities shows it stood at -$313.4 million in 2022, then advanced by 19.78% to -$251.4 million in 2023, then advanced by 4.3% to -$240.6 million in 2024, then plunged by 272.82% to -$897.0 million in 2025, then soared by 58.84% to -$369.2 million in 2026.
• The last three Cash from Financing Activities figures came in at -$369.2 million (Q1 2026), -$897.0 million (Q4 2025), and $483.8 million (Q3 2025), per Business Quant data.